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This Month in the Journal
Epigenotype–Phenotype Relationships in BWS, by
DeBaun et al. (p. 604)
Through a registry-based case-cohort study, DeBaun et
al. make epigenotype-phenotype correlations in Beck-
with-Wiedemann syndrome (BWS). The cardinal fea-
tures of this syndrome are midline abdominal-wall de-
fects, macrosomia, and macroglossia (enlargement of the
tongue) in neonates. Affected individuals are also at in-
creased risk of specific types of cancer. Several genetic
and epigenetic alterations in the chromosome 11p15 re-
gion have been associated with BWS, including abnor-
mal methylation of a region upstream of H19 and loss
of imprinting of IGF2, but associations between these
alterations and specific aspects of the BWS phenotype
have not been thoroughly dissected. DeBaun et al. dis-
cover an association between abnormal methylation of
H19 and embryonal cancer. Bliek et al. (see reference in
DeBaun et al.) previously had found evidence suggestive
of this association, but DeBaun et al. show that this
association is specific to theH19methylation defect and
not to uniparental disomy of the region. DeBaun et al.
also find associations between abnormal methylation of
LIT1 and macrosomia and midline abdominal-wall de-
fects and between paternal uniparental disomy of 11p15
and hemihypertrophy, cancer, and hypoglycemia.
Mutation Studies, by Huang et al. (p. 625)
The simplest model invoked to describe mutations at
microsatellite loci is the stepwise mutation model
(SMM). This model assumes that microsatellites change
by only one repeat unit per mutation and that the prob-
abilities of addition and deletion are constant across al-
leles. Huang et al. directly detect mutation events, in
pedigree genotypes, to investigate mutation patterns at
1300 autosomal dinucleotide microsatellite loci in hu-
mans. They find evidence that microsatellite mutation
events are actually much more complex than is suggested
by the SMM. To begin, most (63%) mutation events are
actually multistep rather than one-step. This is in con-
trast to results in previous studies, in which 15% of the
mutations were multistep. In addition, longer alleles tend
to lose repeat units, whereas shorter alleles tend to gain
them. Overall, there was, in the study, a net loss of 59
repeat units, and the authors suggest that this size-de-
pendent mutation bias may serve as a potential mech-
anism for allele-size constraint.
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TRIM32 Mutation Associated with LGMD2H, by Frosk
et al. (p. 663)
Frosk et al. believe that they have identified a causative
mutation for limb-girdle muscular dystrophy type 2H
(LGMD2H). This relatively mild form of autosomal re-
cessive muscular dystrophy, which has both an onset
during the 2d or 3d decade of life and slow progression,
has so far been identified only in the Hutterite popula-
tion of North America. Fine mapping was used to limit
the LGMD2H critical region, on chromosome 9q31-33,
to a segment containing only four genes, which were
then analyzed by single-stranded conformational anal-
ysis and DNA sequencing. Four polymorphisms were
identified, but only one segregated with the disorder and
was predicted to have an effect on the encoded protein.
This polymorphism results in an aspartate-to-asparagine
substitution in TRIM32 and is found in all 35 affected
individuals in the study. TRIM32 is expressed in a va-
riety of tissues, including skeletal muscle, and the mu-
tation occurs at a conserved residue. On the basis of
presence of a RING-finger domain, TRIM32 is thought
to be an E3-ubiquitin ligase. This led the authors to
speculate about potential disease mechanisms, including
one based on the pathogenesis of Parkinson disease in
individuals with mutations in PARK2, which also en-
codes an E3-ubiquitin ligase. There, neuronal death is
believed to result from accumulation of proteins that are
no longer ubiquitinated and that therefore are not di-
rected to the proteasome for degradation. Similar toxic
accumulations of proteins in muscle tissue may result
from mutations in TRIM32.
Gene Defects in LMNA Cause AR-CMT2, by
De Sandre-Giovannoli et al. (p. 726)
De Sandre-Giovannoli et al. have discovered in LMNA
a mutation that is associated with Charcot-Marie-Tooth
disorder, a group of peripheral neuropathies withmuscle
wasting, foot deformities, and walking difficulties due
to reduced or absent tendon reflexes. This R298C mis-
sense substitution, seen on the same haplotype in three
Algerian families, is the first mutation associated with
autosomal recessive axonal Charcot-Marie-Tooth type
2 (CMT2). Further support for its involvement in CMT
is the fact that homozygous Lmna-knockout mice show
a peripheral-nerve histology similar to that seen in in-
dividuals affected with CMT, including a reduction in
axon density and an increase in the presence of non-
myelinated axons. LMNA encodes lamin A/C, a nuclear-
envelope protein. Mutations in this gene have also been
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associated with limb-girdle muscular dystrophy, dilated
cardiomyopathy, Emery-Dreifuss muscular dystrophy,
and a lipodystrophy. The authors propose that distinct
functional domains essential for the integrity of different
cell lineages may exist in lamin A/C and that these do-
mains may be the explanation for the range of disorders
resulting from LMNA mutations. The domain in which
a particular mutation falls may determine the resulting
phenotype. The CMT2-associated mutation is located in
the rod domain of lamin A/C, a highly conserved domain
essential for protein/protein interactions, and it is, in
fact, predicted to disrupt protein interactions. It seems
likely that this domain is normally fundamentally in-
volved in axon development or survival.
Agouti Signaling Protein and Human Pigmentation,
by Kanetsky et al. (p. 770)
In mice, the agouti signaling protein (ASP) is known to
influence, through its interaction with melanocyte-stim-
ulating hormone receptor (MSHR), the relative produc-
tion of the pigments eumelanin and pheomelanin. In
humans, variation in the gene for MSHR, MC1R, is
associated with pigmentation variation and with risk of
melanoma and nonmelanoma skin cancers, but similar
associations for agouti signaling protein have not been
identified. In a sample of white individuals, Kanetsky et
al. characterize genetic variation in ASIP, the gene for
agouti signaling protein. Although the ASIP coding
regions lacked variation, a polymorphism, g.8818ArG,
was found in the 3′ UTR. The G allele at this position
was significantly associated with dark hair and with
brown eyes but not with susceptibility to melanoma.
This report provides the first evidence of a role for ASIP
in human pigmentation. Because ASP and MSHR inter-
act, at least in mice, the authors note that a combination
of ASIP and MC1R may show a stronger association
with pigmentation than do the individual genotypes, al-
though this has not yet been examined.
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